Loading...
Docoh

Dr. Reddy`s Laboratories (RDY)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API or bulk drugs, which are principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research, development, and manufacture of differentiated formulations and new chemical entities. The Others segment includes the operations of the wholly-owned subsidiary of the company, Aurigene Discovery Technologies Limited, a discovery stage biotechnology company developing novel and best-in-class therapies in the fields of oncology and inflammation and which works with pharmaceutical and biotechnology companies in early-stage collaborations, brining drug candidates for pre-clinical development. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

RDY stock data

Analyst ratings and price targets

Last 3 months

Calendar

27 Jun 22
16 Aug 22
31 Mar 23
Quarter (USD) Mar 22 Mar 21 Mar 20 Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Mar 22 Mar 21 Mar 20 Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

?
Competition
Sanofi

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: aa, ADC, administeredby, alert, Alium, Allegany, alongside, alsonotify, ALSP, AmeriHealth, Amgen, andcould, anEIR, antigen, Aquestive, arewere, Ashoka, ation, Authorityand, awardsentitl, backward, BDSI, beverage, Beverley, billion, bio, BioDelivery, Boehringer, Bok, bone, broader, BsUFA, cadre, capitaliz, carbon, catastrophic, CCG, CDI, CDMO, ceremony, certainof, Certificado, CFEH, Chemplast, chimeric, CHMP, Ciprolet, Clair, Clayton, Clinton, Cloxacillin, Collector, Combihale, Companyhad, Conceptual, conjugate, conservation, contacted, Cook, Cortland, courtwere, covenant, CTCL, Culverson, Czech, Daffy, Debenture, deferral, degradation, Delhivery, denileukin, Derivativeswhich, detention, diftitox, dimethyl, disregarded, DPAC, ed, eferred, efund, ELYXYB, Entrepreneurship, epreciation, equitable, ertapenem, Eton, faculty, FDAindicating, flat, fo, formula, FPM, Franklin, frequency, Fulton, fusion, gas, gather, geopolitical, greenhouse, ground, Gwendolyn, hare, hasc, headcount, Herkimer, Hong, hypertension, icosapent, ID, IEPF, ignificant, Illustrative, immunology, inducted, indust, infant, Ingelheim, intragroup, irregular, IRS, iteration, itss, JMC, Joseph, JP, JSC, Karnataka, Kong, Krishnan, Kulkarni, laid, lean, Levolet, liberty, Madison, Magnolia, Mangalore, Mankind, manufacturingor, martial, Medac, mental, merged, messenger, Middleburgh, Minister, MOA, Monash, Montgomery, moreperformance, mRNA, NAER, Narasimham, Nassau, NBE, neighboring, NGO, Niagara, nutrition, OAI, odify, ofthe, ompany, oncertain, onset, ontract, Orchid, orindirectly, orrectly, paymentreceived, peak, Penny, piecemeal, pioneer, Portugal, postponed, postponement, PraecipeFor, preclusion, Prime, proper, provisional, PS, pulmonary, receiveda, receptor, recogniz, recourse, Reg, reinforced, relocated, representsthe, resiliency, Rural, ry, safer, samewere, Schenectady, score, secretariat, Shanghai, shortly, Shriram, sizable, Slovakia, spearheaded, Steuben, stronger, subsidiaryAurigene, Sushrut, Sweat, Sweden, Tcell, Temasek, Thai, THB, TheC, thefollowing, theyear, tiered, tighter, tolerability, toxin, unaffected, unfit, uniform, URRA, utiliz, vasopressin, Veraring, viii, Wan, war, Westchester, wholeseller, workplace, Wyeth, xpert, yearsended, Yorkshire, zealously
Removed: abandon, Abbvie, Addiction, admission, advocacy, Affordability, Allen, anticipation, arisen, Asian, aspect, attaching, attracting, augmenting, avoiding, awaiting, banning, baseline, BBA, Belgium, benchmark, Bennett, Bharat, Biotech, Bipartisan, blocking, bona, Booz, BuFA, Bupa, Cautionary, Chakraborty, chamber, chiral, clarification, clobetasol, clocortolone, Cloderm, closer, Coleman, collaborate, column, comment, comparative, concentrated, coordinate, Dabur, daily, Deccan, declining, deficit, desired, desperately, differentiate, discontinue, diverging, Doshi, Duma, easier, Eicher, eisai, Electric, Eli, emanated, encounter, enjoy, enrolling, entitle, entrenched, EPI, Eurobridge, exclusively, fewer, fide, fluctuation, footprint, formally, fundamental, Ganadhish, gauge, Goa, greatest, grown, Hamilton, harbor, Harvard, Herald, Hospira, HR, hydrochloride, Hydrogen, IMA, immigration, imperative, implanted, Impoyz, inappropriate, inducement, inflationary, influential, infusion, instilled, insufficient, integrating, interact, Intertrade, intranasal, IP, ISPE, ITM, JIBAR, Johannesburg, Kamat, KGaA, landlord, Libre, Lilly, linked, lose, lucrative, Max, Mechanical, Meridian, mini, misuse, Narotam, narrowing, negotiated, netting, Northern, older, OOO, outward, Oxley, parenteral, PDA, Pharmacia, Pharmacopeia, Physiology, Pilani, pivalate, plaque, possessing, potency, PPACA, propionate, publishing, Qualcomm, rand, randomized, Raymond, RCP, reassessed, redefining, referendum, reiterated, reliant, removing, renegotiate, renewable, rental, reprioritization, rich, Salzburg, Saumen, SE, Seminar, serving, specificity, Squibb, Stanford, steroid, stringently, strive, successor, symtouch, systematic, Tecumseh, Tourism, trianex, unchanged, unconstitutional, Universit, unrest, Upjohn, valedictorian, vi, Vr, wage, xenoport, Yugandhar, zonal
Proxies
No filings